Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibitionMcKenzie Crist(University of Cincinnati), Trisha M. Wise‐Draper(University of Cincinnati)Journal for ImmunoTherapy of CancerNovember 1, 202210.1136/jitc-2022-005632Cited by 68SaveCiteExport RISWatch citationsRelated PapersAssociation of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium|Annals of Oncology|2021|326